News - BioPharm International

ADVERTISEMENT

News

HydRIS Vaccine Stability Device Could Revolutionize Cold-Chain Requirements

October 2, 2014

Nova Bio-Pharma Technologies' new vaccine stability device eliminates the need for cold storage.

Making ZMapp: Production of Experimental Drug to Treat Ebola Is Now A Priority

October 2, 2014

Manufacturing drugs from biological sources sometimes can't be rushed, even when a rare disease becomes more widespread.

New Tax Rules May Deter Future Pharma M&A

October 1, 2014

Inversions in the pharmaceutical sector could become less lucrative as a result of new tax laws.

New Report Details Players and Pipelines in the Biosimilar Space

September 30, 2014

A new Thomson Reuters BioWorld report outlines the more than 700 biosimilars that are currently in development and the emerging business opportunities that exist in the biopharmaceutical space.

NIH Seeks to Improve Vaccine Response with New Adjuvants

September 30, 2014

NIH seeks new therapeutic products to bolster the protective properties of vaccines.

Baxter International Plans to Open R&D Center for Baxalta

September 30, 2014

Baxter International announced it will form a R&D center in Cambridge, Massachusetts for its new biopharmaceutical company, Baxalta.

FDA and NIH Win Award for IP Licensing of Meningitis Vaccine

September 26, 2014

Partnership is awarded for licensing of low-cost vaccine for the treatment of bacterial meningitis.

FDA Releases First-Ever Purple Book for Biosimilar Characterization

September 26, 2014

The Purple Book will list biologic and biosimilar products and will serve as a guide for interchangeability.

FDA Releases REMS Report

September 25, 2014

FDA report details risk mitigation projects.

ADVERTISEMENT

ADVERTISEMENT

Click here